A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov.
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
Frustrated by spiraling drug costs, California lawmakers want to increase oversight of pharmaceutical industry intermediaries ...
CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...
Chief Executive David Joyner spent a lot of time on the post-earnings call with analysts defending PBMs, or what critics have called "drug middlemen." CVS is a PBM through its CVS Caremark business.
7don MSN
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
CVS’s stock soared toward a three-month high after its quarterly profit beat expectations by the widest margin in more than four years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results